Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial

Abstract

The safety and efficacy of mycophenolate mofetil (MMF) were evaluated in adolescent patients with systemic lupus erythemathosus and active or active/chronic class III-V lupus nephritis.

Keywords

• Mycophenolate mofetil
• lupus nephritis
• adolescent
• induction
• ayathioprine